Results 1 to 10 of about 157,838 (114)
The dissolution of aspirin and aspirin tablets [PDF]
Journal of Pharmacy and Pharmacology, 1967 Abstract An attempt has been made to standardize the “beaker” method of measuring in vitro dissolution rates of tablets against published data for aspirin. An unexpected problem arose when it was found that samples of commercial aspirin have different intrinsic dissolution rates.
Dorothy J. Saville, A. G. Mitchell
openaire +2 more sources
Thorax, 2000 Aspirin or acetylsalicylic acid (ASA) is still one of the most widely sold drugs in the world and its side effects are well known. Among these, hypersensitivity reactions represent one of the most frequently described since the first report of urticaria and angio-oedema by Hirshberg in 1902.1 The hypersensitivity reactions to aspirin may be divided ...
Nucera, Eleonora +6 more
openaire +5 more sources
Obstetrics & Gynecology Science, 2023 Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities.
Tae Gyu Ahn, Jong Yun Hwang
openaire +3 more sources
Advances in Hematology, 2009 The development of adverse cardiovascular events despite aspirin use has established an interest in a possible resistance to the drug. Several definitions have been set and various laboratory testing modalities are available. This has led to a wide range of prevalence reports in different clinical entities.
Khaled Mansour +3 more
openaire +3 more sources
Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin [PDF]
Thrombosis, 2012 Acetyl salicylic acid or aspirin is one of the most famous drugs in the world. Aspirin has been increasingly used for prevention of cardiovascular events and is, particularly in recent decades, the most used nonsteroidal anti-inflammatory drug. Thus, it was necessary to have several contributions to precise the interest and the side effects of ...
openaire +3 more sources
Journal of the American College of Cardiology, 2016 The place of aspirin in primary prevention remains controversial, with North American and European organizations issuing contradictory treatment guidelines. More recently, the U.S. Preventive Services Task Force recommended "initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer in adults aged ...
PATRIGNANI, Paola, Patrono, Carlo
openaire +5 more sources
Effect of aspirin in "aspirin sensitive" patients. [PDF]
BMJ, 1984 Eighteen patients with a history of urticaria or asthma, or both, induced by aspirin were studied before and after provocation of symptoms with aspirin. The plasma prostaglandin F2 alpha concentration, which was characteristically raised before challenge, fell significantly at the time of adverse reactions.
A W Frankland +4 more
openaire +3 more sources
Archives of Neurology, 1990 In our recent article, 1 we reviewed the available evidence on aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. We concluded that low-dose aspirin should be a possible adjunct, not an alternative, to coronary risk factor management and, in view of its possible side effects, should be prescribed ...
Buring, J +4 more
openaire +3 more sources
British Journal of Surgery, 2002 OBJECTIVE: To review the literature addressing the problem of aspirin resistance in patients with vascular disease. DATA SOURCES: A MEDLINE search (1966–February 2002) was performed. Key search terms included aspirin, resistance, resistant, failure, tolerance, and nonresponder.
Gerard Stansby, J. Smout
openaire +6 more sources